Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma

被引:9
|
作者
Pomyen, Yotsawat [1 ]
Chaisaingmongkol, Jittiporn [2 ,3 ]
Rabibhadana, Siritida [2 ]
Pupacdi, Benjarath [1 ]
Sripan, Donlaporn [2 ]
Chornkrathok, Chidchanok [2 ]
Budhu, Anuradha [4 ,5 ]
Budhisawasdi, Vajarabhongsa [2 ,6 ]
Lertprasertsuke, Nirush [7 ]
Chotirosniramit, Anon [7 ]
Pairojkul, Chawalit U. [6 ]
Auewarakul, Chirayu [8 ]
Ungtrakul, Teerapat [8 ]
Sricharunrat, Thaniya [9 ]
Phornphutkul, Kannikar [10 ]
Sangrajang, Suleeporn A. [11 ]
Loffredo, Christopher C. [12 ]
Harris, Curtis [5 ]
Mahidol, Chulabhorn [2 ]
Wang, Xin Wei [4 ,5 ]
Ruchirawat, Mathuros [2 ,3 ]
机构
[1] Chulabhorn Res Inst, Translat Res Unit, Bangkok 10210, Thailand
[2] Chulabhorn Res Inst, Lab Chem Carcinogenesis, Bangkok 10210, Thailand
[3] MHESI, Ctr Excellence Environm Hlth & Toxicol EHT, OPS, Bangkok, Thailand
[4] NCI, Liver Canc Program, Ctr Canc Res, Bethesda, MD 20892 USA
[5] NCI, Lab Human Carcinogenesis, Ctr Canc Res, Bethesda, MD 20892 USA
[6] Khon Kaen Univ, Fac Med, Khon Kaen 40002, Thailand
[7] Chiang Mai Univ, Fac Med, Chiang Mai 50200, Thailand
[8] Chulabhorn Royal Acad, Princess Srisavangavadhana Coll Med, Bangkok 10210, Thailand
[9] Chulabhorn Royal Acad, Chulabhorn Hosp, Bangkok 10210, Thailand
[10] Rajavej Hosp, Chiang Mai 50000, Thailand
[11] Natl Canc Inst, Bangkok 10400, Thailand
[12] Georgetown Univ, Med Ctr, Washington, DC 20057 USA
关键词
RISK-FACTORS; MICROBIOME; GENES;
D O I
10.1038/s41598-023-38307-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Primary liver cancer (PLC), which includes intrahepatic cholangiocarcinoma (iCCA) and hepatocellular carcinoma (HCC), has the highest incidence of all cancer types in Thailand. Known etiological factors, such as viral hepatitis and chronic liver disease do not fully account for the country's unusually high incidence. However, the gut-liver axis, which contributes to carcinogenesis and disease progression, is influenced by the gut microbiome. To investigate this relationship, fecal matter from 44 Thai PLC patients and 76 healthy controls were subjected to whole-genome metagenomic shotgun sequencing and then analyzed by marker gene-based and assembly based methods. Results revealed greater gut microbiome heterogeneity in iCCA compared to HCC and healthy controls. Two Veillonella species were found to be more abundant in iCCA samples and could distinguish iCCA from HCC and healthy controls. Conversely, Ruminococcus gnavus was depleted in iCCA patients and could distinguish HCC from iCCA samples. High Veillonella genus counts in the iCCA group were associated with enriched amino acid biosynthesis and glycolysis pathways, while enriched phospholipid and thiamine metabolism pathways characterized the HCC group with high Blautia genus counts. These findings reveal distinct landscapes of gut dysbiosis among Thai iCCA and HCC patients and warrant further investigation as potential biomarkers.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma
    Ru-Chen Xu
    Fu Wang
    Jia-Lei Sun
    Weinire Abuduwaili
    Guang-Cong Zhang
    Zhi-Yong Liu
    Tao-Tao Liu
    Ling Dong
    Xi-Zhong Shen
    Ji-Min Zhu
    Journal of Translational Medicine, 20
  • [42] Computed Tomography Radiomics to Differentiate Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
    Mahmoudi, S.
    Bernatz, S.
    Ackermann, J.
    Koch, V.
    Dos Santos, D. P.
    Gruenewald, L. D.
    Yel, I.
    Martin, S. S.
    Scholtz, J. -E
    Stehle, A.
    Walter, D.
    Zeuzem, S.
    Wild, P. J.
    Vogl, T. J.
    Kinzler, M. N.
    CLINICAL ONCOLOGY, 2023, 35 (05) : E312 - E318
  • [43] Histomorphological Subtypes of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Review and Update
    Hwang, Yoon Jung
    Kim, Haeryoung
    AJSP-REVIEWS AND REPORTS, 2022, 27 (06) : 234 - 240
  • [44] Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
    Kis, Bela
    El-Haddad, Ghassan
    Sheth, Rahul A.
    Parikh, Nainesh S.
    Ganguli, Suvranu
    Shyn, Paul B.
    Choi, Junsung
    Brown, Karen T.
    CANCER CONTROL, 2017, 24 (03)
  • [45] Comparison of Serum Tumor Markers for Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
    Tao, Lian-Yuan
    Cai, Lei
    He, Xiao-Dong
    Liu, Wei
    Qu, Qiang
    AMERICAN SURGEON, 2010, 76 (11) : 1210 - 1213
  • [46] Stereotactic Body Radiosurgery for Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
    Lederman, A. J.
    Loksen, M.
    Shao, M.
    Kil, A. M.
    Osborn, V.
    Lee, A.
    Lederman, G. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E178 - E178
  • [47] A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma
    Xu, Ru-Chen
    Wang, Fu
    Sun, Jia-Lei
    Abuduwaili, Weinire
    Zhang, Guang-Cong
    Liu, Zhi-Yong
    Liu, Tao-Tao
    Dong, Ling
    Shen, Xi-Zhong
    Zhu, Ji-Min
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [48] Roles of the gut microbiota in hepatocellular carcinoma: from the gut dysbiosis to the intratumoral microbiota
    Wang, Yiqin
    Li, Yongqiang
    Lin, Yong
    Cao, Chuangyu
    Chen, Dongcheng
    Huang, Xianguang
    Li, Canhua
    Xu, Haoming
    Lai, Huasheng
    Chen, Huiting
    Zhou, Yongjian
    CELL DEATH DISCOVERY, 2025, 11 (01)
  • [49] Differential miRNA Analysis of Combined Hepatocellular-Cholangiocarcinoma in Comparison to Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Pilot Study
    Malik, Preeti
    Huang, Yan
    Castrodad-Rodriguez, Carlos
    Lin, Juan
    Loudig, Olivier
    Bhalla, Amarpreet
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1137 - 1139
  • [50] Differential miRNA Analysis of Combined Hepatocellular-Cholangiocarcinoma in Comparison to Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Pilot Study
    Malik, Preeti
    Huang, Yan
    Castrodad-Rodriguez, Carlos
    Lin, Juan
    Loudig, Olivier
    Bhalla, Amarpreet
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1137 - 1139